We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
-13.18%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$480M
AUM Growth
-$62.8M
(-12%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
4.03%
Top 10 Holdings %
Top 10 Hldgs %
63.98%
Holding
64
New
7
Increased
24
Reduced
17
Closed
4
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
+$10.4M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$5.38M |
| 3 |
Denali Therapeutics
DNLI
|
+$5.07M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$4.16M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$3.88M |
Top Sells
| 1 |
Biogen
BIIB
|
+$5.47M |
| 2 |
Merck
MRK
|
+$3.85M |
| 3 |
Tesla
TSLA
|
+$2.68M |
| 4 |
Arrowhead Research
ARWR
|
+$1.98M |
| 5 |
VZLA
Vizsla Silver
VZLA
|
+$1.12M |
Sector Composition
| 1 | Healthcare | 33.85% |
| 2 | Consumer Discretionary | 24.98% |
| 3 | Technology | 24.21% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 6.76% |
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM